コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ntrol group of transplanted patients without neurologic complications.
2 ion, and Charcot-Marie Tooth disease without neurologic complications.
3 sk patients may help reduce the incidence of neurologic complications.
4 een shown and is known to cause vascular and neurologic complications.
5 fluential factor that increased risk of late neurologic complications.
6 nd foramen magnum stenosis can cause serious neurologic complications.
7 edural factors significantly associated with neurologic complications.
8 There were no BA-related deaths or neurologic complications.
9 Is) are associated with rare but devastating neurologic complications.
10 s later to cause shingles (zoster) and other neurologic complications.
11 There were no permanent neurologic complications.
12 out further systemic therapy, none with late neurologic complications.
13 ts, retrograde cerebral perfusion eliminated neurologic complications.
14 lopment and progression of microvascular and neurologic complications.
15 36 +/- 0.4 vs. 1.24 +/- 0.4 mg/dL, p < .02), neurologic complications (3% vs. 1.6%, p < .001), nosoco
16 C deficiency can produce the hematologic and neurologic complications after birth, whereas TCblR/CD32
17 trapontine myelinolysis (CPM/EPM) are severe neurologic complications after liver transplantation.
20 ngs with CDG-IIb who presented with multiple neurologic complications and a paradoxical immunologic p
21 ction to acute febrile illnesses with severe neurologic complications and accounts for a significant
22 n underscore possible concern for additional neurologic complications and nonarthropod-mediated trans
23 of life; however, the mechanisms underlying neurologic complications and their impact on outcomes in
24 difference in survival between patients with neurologic complications and without (90-day mortality:
25 tion of extracorporeal membrane oxygenation, neurologic complications, and presence of more than thre
32 groups with respect to the rate of stroke or neurologic complications at the time of discharge (P=0.8
33 (HIV) is associated with a high frequency of neurologic complications due to infection of the central
34 l leukoencephalopathy (PML) in patients with neurologic complications due to infection with human imm
37 ndently associated with an increased risk of neurologic complication included the indication of ather
38 concern, particularly given the high risk of neurologic complications (including Guillain-Barre syndr
39 s zoster can be associated with a variety of neurologic complications, including a syndrome of delaye
41 nt association between Zika virus (ZIKV) and neurologic complications, including Guillain-Barre syndr
45 al fluid (CSF) diversion (n=54) and/or other neurologic complications (n=40), more than half of which
54 ent review summarizes common problems in the neurologic complications of leukemia and discusses recen
55 his method of treatment has no effect on the neurologic complications of liver failure and has no imp
58 xamined specifically for musculoskeletal and neurologic complications of Paget disease, including fra
59 y respiratory related, but cardiovascular or neurologic complications or exacerbations of underlying
62 ion of test scores or the parents' report of neurologic complications, psychotropic drug use, and spe
66 us extraintestinal manifestations, including neurologic complications such as neuropathy, ataxia, sei
67 er, in this communication, we report a major neurologic complication that resulted in anterior spinal
68 ar survival: 51.1% in patients who developed neurologic complication versus 62.1% in patients who did
69 day mortality: 15% of patients who developed neurologic complications versus 4% of patients who did n
70 nd their role in the pathogenesis of delayed neurologic complications warrants further investigation.
71 endently associated with a decreased risk of neurologic complication were increasing chronologic year
75 ion control, and avoidance of thromboembolic neurologic complications will be crucial to the success
76 Seventy (9.2%) patients experienced major neurologic complications within 2 weeks after lung trans
78 points included complete aneurysm occlusion; neurologic complications within 30 days and up to 3 year
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。